Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study.
Colorectal cancer
E-PASS
Recurrence
Journal
Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
09
10
2022
accepted:
12
12
2022
medline:
27
7
2023
pubmed:
16
2
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
We determined the usefulness of the estimation of physiologic ability and surgical stress (E-PASS), initially reported as a predictive factor for postoperative morbidity and mortality, as a prognostic indicator in stage II colorectal cancer (CRC). Overall, 739 patients who underwent proctocolectomy for CRC at Tottori University Hospital and affiliated hospitals and histologically diagnosed with stage II CRC were included in the current study. A receiver operating characteristic (ROC) analysis of the five-year recurrence-free survival indicated that the comprehensive risk score (CRS) of E-PASS predicted postoperative recurrence. A multivariate analysis revealed that the presence of preoperative perforation, T4, v ≥ 2, and CRS The CRS predicts postoperative recurrence in patients with stage II CRC.
Identifiants
pubmed: 36790474
doi: 10.1007/s00595-023-02656-2
pii: 10.1007/s00595-023-02656-2
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
949-956Informations de copyright
© 2023. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.
Références
Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:3408–19.
doi: 10.1200/JCO.2004.05.063
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21:v70-7.
doi: 10.1093/annonc/mdq168
pubmed: 20555107
Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41.
doi: 10.1016/j.ejca.2011.03.028
pubmed: 21724383
Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34:1303–15.
doi: 10.1007/s00384-019-03316-z
pubmed: 31177316
Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36:995–1001.
pubmed: 26976989
Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7:58543–52.
doi: 10.18632/oncotarget.10148
pmcid: 5295450
Yamamoto M, Saito H, Uejima C, Tanio A, Tada Y, Matsunaga T, et al. Estimation of physiological ability and surgical stress score is a useful prognostic indicator for elderly patients with colorectal cancer. Dig Surg. 2020;37:145–53.
doi: 10.1159/000497455
pubmed: 30844817
Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, et al. Evaluation of the estimation of physiologic ability and surgical stress score as a prognostic indicator for older patients with gastric cancer. Dig Surg. 2020;37:171–8.
doi: 10.1159/000497457
pubmed: 30844794
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. Tokyo, Japan: Kanehara & Co., Ltd; 2018.
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.
pubmed: 6438478
Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (the E-PASS score) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29:219–25.
doi: 10.1007/BF02483010
pubmed: 10192731
André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.
doi: 10.1056/NEJMoa032709
Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011;29:1465–71.
doi: 10.1200/JCO.2010.33.6297
pubmed: 21383294
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.
doi: 10.1007/s10147-019-01485-z
pubmed: 31203527
Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, et al. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial. Eur J Cancer. 2018;96:54–63.
doi: 10.1016/j.ejca.2018.03.009
pubmed: 29677641
Miyatani K, Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, et al. Combined analysis of the pre- and postoperative neutrophil–lymphocyte ratio predicts the outcomes of patients with gastric cancer. Surg Today. 2018;48:300–7.
doi: 10.1007/s00595-017-1587-6
pubmed: 28916967
Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Qin A, et al. Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer. Lung Cancer. 2022;163:35–41.
doi: 10.1016/j.lungcan.2021.11.021
pubmed: 34896803
Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, et al. Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients. Langenbecks Arch Surg. 2017;402:501–7.
doi: 10.1007/s00423-017-1572-y
Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37:2688–92.
doi: 10.1007/s00268-013-2156-9
pubmed: 23884382
Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271:693–700.
doi: 10.1097/SLA.0000000000002985
pubmed: 30308614
Arai Y, Saito H, Ikeguchi M. Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T cells associated with dysfunction of cell-mediated immunity after colorectal cancer operation. Yonago acta med. 2012;55:1–9.
pubmed: 24031134
pmcid: 3727487